143.07
전일 마감가:
$138.10
열려 있는:
$142.28
하루 거래량:
2.41M
Relative Volume:
1.37
시가총액:
$9.49B
수익:
$409.48M
순이익/손실:
$-81.28M
주가수익비율:
-107.68
EPS:
-1.3286
순현금흐름:
$-95.14M
1주 성능:
+13.98%
1개월 성능:
+20.66%
6개월 성능:
+217.86%
1년 성능:
+428.32%
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, IQV, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp
|
143.07 | 8.43B | 409.48M | -81.28M | -95.14M | -1.3286 |
|
TMO
Thermo Fisher Scientific Inc
|
648.43 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
208.36 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
345.34 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
268.82 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
A
Agilent Technologies Inc
|
153.69 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 개시 | Stephens | Overweight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia - investing.com
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia By Investing.com - Investing.com Australia
Twist Bioscience HR SVP Paula Green Sells Shares to Cover RSU Tax Withholding - Kalkine Media
TWST Initiated Coverage by BWS Financial -- Current Rating: Sell - GuruFocus
BWS Financial initiates Twist Bioscience stock with sell rating - investing.com
TWST Initiates Coverage On UBS -- Rating Set at Neutral with $144 Target - GuruFocus
BWS Financial initiates Twist Bioscience stock with sell rating By Investing.com - Investing.com India
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference - BioSpace
After $14M August sale, Twist Bioscience (NASDAQ: TWST) investor plans another stock sale - Stock Titan
Officer at Twist Bioscience (TWST) preps 907-share sale - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell shares, including stock to cover taxes - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer plans about $50K stock sale - Stock Titan
Cathie Wood’s ARK reveals stake in Twist Bioscience (NASDAQ: TWST) - Stock Titan
Claim your share of the $17 million Twist Bioscience securities class action settlement - claimdepot.com
An investor holds voting power over 8.8M Twist Bioscience (TWST) shares - Stock Titan
Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand - Yahoo Finance
Twist Bioscience (NASDAQ: TWST) HR chief reports tax-driven stock sale - Stock Titan
About Twist Bioscience Corporation • Robinhood Token - Coinbase
Cathie Wood’s ARK sees major stock moves with Robinhood and Twist Bioscience - investing.com
Twist Bioscience Corp (TWST) Shares Fall 3.0% -- What GF Score o - GuruFocus
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 - Moomoo
Twist Bioscience Corp (TWST) Stock Down 5.0% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Slides as Investors Appear to Cool on Recent AI-Fueled Rally - Quiver Quantitative
Twist Bioscience Corp (TWST) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Twist Bioscience (NASDAQ: TWST) insider sells millions in stock - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer sets 854-share sale tied to equity taxes - Stock Titan
Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media
Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade
Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan
Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan
Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com
Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat
Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada
Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com
Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart
Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com
Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan
Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga
Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com
Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan
Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative
TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus
Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
트위스트 바이오사이언스 주식 (TWST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Green Paula | SVP of Human Resources |
Sep 08 '26 |
Sale |
122.62 |
907 |
111,220 |
117,014 |
| Leproust Emily M. | Chief Executive Officer |
Sep 08 '26 |
Sale |
122.62 |
2,302 |
282,280 |
768,427 |
| WERNER ROBERT F. | Chief Accounting Officer |
Sep 08 '26 |
Sale |
122.62 |
238 |
29,185 |
44,399 |
자본화:
|
볼륨(24시간):